|
SEPT7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.92180000000175E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.12080000011805E-07 |
| Normal-vs-Stage2 |
5.735700E-02 |
| Normal-vs-Stage3 |
5.683300E-03 |
| Normal-vs-Stage4 |
1.926390E-02 |
| Stage1-vs-Stage2 |
7.328000E-01 |
| Stage1-vs-Stage3 |
2.033400E-01 |
| Stage1-vs-Stage4 |
4.276000E-02 |
| Stage2-vs-Stage3 |
7.586600E-01 |
| Stage2-vs-Stage4 |
5.192600E-01 |
| Stage3-vs-Stage4 |
5.721200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52909999995288E-06 |
| Normal-vs-AfricanAmerican |
2.719200E-01 |
| Normal-vs-Asian |
9.872400E-02 |
| Caucasian-vs-AfricanAmerican |
1.132250E-02 |
| Caucasian-vs-Asian |
9.709800E-01 |
| AfricanAmerican-vs-Asian |
3.541800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.09639999999567E-05 |
| Normal-vs-Female |
1.203930E-04 |
| Male-vs-Female |
7.161600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.058100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.97959000000081E-05 |
| Normal-vs-Age(61-80Yrs) |
1.440250E-04 |
| Normal-vs-Age(81-100Yrs) |
4.269400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.687000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.714000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.882300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.969800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.517230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.070400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.213100E-04 |
| Normal-vs-Grade 2 |
5.7443000023305E-08 |
| Normal-vs-Grade 3 |
8.321400E-03 |
| Normal-vs-Grade 4 |
4.961800E-02 |
| Grade 1-vs-Grade 2 |
6.908000E-01 |
| Grade 1-vs-Grade 3 |
1.407760E-02 |
| Grade 1-vs-Grade 4 |
5.044400E-02 |
| Grade 2-vs-Grade 3 |
1.374320E-04 |
| Grade 2-vs-Grade 4 |
4.576100E-03 |
| Grade 3-vs-Grade 4 |
9.691000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.17319997950239E-09 |
| Normal-vs-ccB subtype |
3.503000E-03 |
| ccA subtype-vs-ccB subtype |
6.780900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.231400E-04 |
| Normal-vs-N1 |
2.434600E-01 |
| N0-vs-N1 |
6.916800E-01 |
|
|
